{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:04:27Z","timestamp":1791572667222,"version":"4.3.4"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T00:00:00Z","timestamp":1710115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pain Res."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Matrix type transdermal buprenorphine patches have not been investigated in horses and may provide an effective means of providing continuous pain control for extended period and eliminating venous catheterization.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>Assessment of the physiological variables (heart rate, respiratory rate, body temperature) and thermal nociceptive threshold testing, and describing the pharmacokinetic profile of transdermal buprenorphine matrix-type patch (20\u2005\u03bcg h<jats:sup>\u22121<\/jats:sup> and 40\u2005\u03bcg h<jats:sup>\u22121<\/jats:sup> dosing) in healthy adult horses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Study design<\/jats:title><jats:p>Randomised experimental study with a Latin-square design.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Six adult healthy horses received each of the three treatments with a minimum 10 day washout period. BUP0 horses did not receive a patch (control). BUP20 horses received one patch (20\u2005\u03bcg h<jats:sup>\u22121<\/jats:sup>) applied on the ventral aspect of the tail base resulting in a dose of 0.03\u20130.04\u2005\u03bcg kg<jats:sup>\u22121<\/jats:sup> h<jats:sup>\u22121<\/jats:sup>. BUP40 horses received two patches placed alongside each other (40\u2005\u03bcg h<jats:sup>\u22121<\/jats:sup>) on the tail base resulting in a dose of 0.07\u20130.09\u2005\u03bcg kg<jats:sup>\u22121<\/jats:sup> h<jats:sup>\u22121<\/jats:sup>. Whole blood samples (for determination of buprenorphine concentration), physiological variables and thermal threshold testing were performed before (0\u2005h) and at 2, 4, 8, 12, 16, 24, 32, 40, 48, 56, 64, 72, and 96\u2005h after patch application. The patches were removed 72\u2005h following placement and were analyzed for residual buprenorphine content.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Between the three groups, there was no change in physiological variables across timepoints as compared to baseline (<jats:italic>p<\/jats:italic>\u2009&amp;gt;\u20090.1). With the higher dose, there was a significant increase in thermal thresholds from baseline values from 2\u2005h until 48\u2005h and these values were significantly higher than the group receiving the lower patch dose for multiple timepoints up to 40\u2005h. 40\u2005\u03bcg h<jats:sup>\u22121<\/jats:sup> patch led to consistent measurable plasma concentrations starting at 2\u2005h up to 96\u2005h, with the mean plasma concentrations of\u2009&amp;gt;\u20090.1\u2005ng\/ml from 4\u2005h to 40\u2005h.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>20\u2005\u03bcg h<jats:sup>\u22121<\/jats:sup> and 40\u2005\u03bcg h<jats:sup>\u22121<\/jats:sup> patch doses were well tolerated by all horses. At higher dose, plasma buprenorphine concentrations were more consistently measurable and blunted thermal thresholds for 48\u2005h vs. 32\u2005h with 20\u2005\u03bcg h<jats:sup>\u22121<\/jats:sup> dosing as compared to control.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpain.2024.1373555","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T04:36:13Z","timestamp":1710131773000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Evaluation of physical variables, thermal nociceptive threshold testing and pharmacokinetics during placement of transdermal buprenorphine matrix-type patch in healthy adult horses"],"prefix":"10.3389","volume":"5","author":[{"given":"Vaidehi V.","family":"Paranjape","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather K.","family":"Knych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Londa J.","family":"Berghaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Cathcart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyla","family":"Giancola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth","family":"Saksena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel A.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.tvjl.2019.02.010","article-title":"Therapeutic developments in equine pain management","volume":"247","author":"Mama","year":"2019","journal-title":"Vet J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/evj.12265","article-title":"Pain control in horses: what do we really know?","volume":"46","author":"Sanchez","year":"2014","journal-title":"Equine Vet J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.2147\/JPR.S270169","article-title":"Characteristics of analgesic patch formulations","volume":"13","author":"Nalamachu","year":"2020","journal-title":"J Pain Res"},{"key":"B4","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3390\/molecules23030681","article-title":"Transdermal and topical drug administration in the treatment of pain","volume":"23","author":"Leppert","year":"2018","journal-title":"Molecules"},{"key":"B5","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1533-2500.2010.00378.","article-title":"Current knowledge of buprenorphine and its unique pharmacological profile","volume":"10","author":"Pergolizzi","year":"2010","journal-title":"Pain Pract"},{"key":"B6","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/j.1476-5381.1977.tb07533.x","article-title":"The animal pharmacology of buprenorphine, an oripavine analgesic agent","volume":"60","author":"Cowan","year":"1977","journal-title":"Br J Pharmacol"},{"key":"B7","first-page":"3","article-title":"Buprenorphine: new pharmacological aspects","volume":"133","author":"Cowan","year":"2003","journal-title":"Int J Clin Pract Suppl"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3468","DOI":"10.3390\/ani12243468","article-title":"Comparison of the transdermal and intravenous administration of buprenorphine in the management of intra- and postoperative pain in dogs undergoing a unilateral mastectomy","volume":"12","author":"Galosi","year":"2022","journal-title":"Animals MDPI"},{"key":"B9","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1365-2885.2009.01058.x","article-title":"Plasma buprenorphine concentrations after the application of a 70 microg\/h transdermal patch in dogs. Preliminary report","volume":"32","author":"Andaluz","year":"2009","journal-title":"J Vet Pharmacol Ther"},{"key":"B10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.tvjl.2009.11.011","article-title":"Comparison of subcutaneous and transdermal administration of buprenorphine for pre-emptive analgesia in dogs undergoing elective ovariohysterectomy","volume":"187","author":"Moll","year":"2011","journal-title":"Vet J"},{"key":"B11","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.tvjl.2010.01.013","article-title":"Antinociceptive efficacy and plasma concentrations of transdermal buprenorphine in dogs","volume":"187","author":"Pieper","year":"2011","journal-title":"Vet J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1136\/vr.160.17.578","article-title":"Use of a transdermal matrix patch of buprenorphine in cats: preliminary pharmacokinetic and pharmacodynamic data","volume":"160","author":"Murrell","year":"2007","journal-title":"Vet Rec"},{"key":"B13","first-page":"692","article-title":"Pharmacokinetics of sustained-release and transdermal buprenorphine in g\u00f6ttingen minipigs (Sus scrofa domestica)","volume":"53","author":"Thiede","year":"2014","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.vaa.2016.09.002","article-title":"Plasma concentrations of transdermal fentanyl and buprenorphine in pigs (Sus scrofa domesticus)","volume":"44","author":"Osorio Lujan","year":"2017","journal-title":"Vet Anaesth Analg"},{"key":"B15","doi-asserted-by":"publisher","first-page":"105936","DOI":"10.1016\/j.ejps.2021.105936","article-title":"Maternal and fetal buprenorphine pharmacokinetics in pregnant sheep during transdermal patch dosing: buprenorphine pharmacokinetics in pregnant sheep","volume":"165","author":"Hakom\u00e4ki","year":"2021","journal-title":"Eur J Pharm Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"106283","DOI":"10.1016\/j.ejps.2022.106283","article-title":"Central nervous system distribution of buprenorphine in pregnant sheep, fetuses and newborn lambs after continuous transdermal and single subcutaneous extended-release dosing","volume":"178","author":"Hakom\u00e4ki","year":"2022","journal-title":"Eur J Pharm Sci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"356","DOI":"10.30802\/AALAS-JAALAS-18-000101","article-title":"Evaluation of analgesic patches in cynomolgus macaques (Macaca fascicularis)","volume":"58","author":"Smith","year":"2019","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"246","DOI":"10.2460\/ajvr.68.3.246","article-title":"Effects of buprenorphine on nociception and spontaneous locomotor activity in horses","volume":"68","author":"Carregaro","year":"2007","journal-title":"Am J Vet Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1136\/vr.g7571","article-title":"Opioids for field procedures in equine practice","volume":"175","author":"Schauvliege","year":"2014","journal-title":"Vet Rec"},{"key":"B20","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/evj.12442","article-title":"A multicentre, prospective, randomised, blinded clinical trial to compare some perioperative effects of buprenorphine or butorphanol premedication before equine elective general anaesthesia and surgery","volume":"48","author":"Taylor","year":"2016","journal-title":"Equine Vet J"},{"key":"B21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/vaa.12165","article-title":"Pharmacokinetic-pharmacodynamic modelling of intravenous buprenorphine in conscious horses","volume":"42","author":"Love","year":"2015","journal-title":"Vet Anaesth Analg"},{"key":"B22","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.vaa.2021.02.005","article-title":"Pharmacokinetics and pharmacodynamics of a high concentration of buprenorphine (simbadol) in conscious horses after subcutaneous administration","volume":"48","author":"Flynn","year":"2021","journal-title":"Vet Anaesth Analg"},{"key":"B23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/vaa.12205","article-title":"Antinociceptive effect of buprenorphine and evaluation of the nociceptive withdrawal reflex in foals","volume":"42","author":"Risberg","year":"2015","journal-title":"Vet Anaesth Analg"},{"key":"B24","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.2042-3306.2011.00412.x","article-title":"Effects of acepromazine, butorphanol and buprenorphine on thermal and mechanical nociceptive thresholds in horses","volume":"44","author":"Love","year":"2012","journal-title":"Equine Vet J"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.3390\/ani10091556","article-title":"Remote controlled nociceptive threshold testing systems in large animals","volume":"10","author":"Taylor","year":"2020","journal-title":"Animals MDPI"},{"key":"B26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1746-6148-9-135","article-title":"Nociceptive thermal threshold testing in horses\u2014effect of neuroleptic sedation and neuroleptanalgesia at different stimulation sites","volume":"9","author":"Poller","year":"2013","journal-title":"BMC Vet Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1746-6148-9-4","article-title":"Evaluation of contact heat thermal threshold testing for standardized assessment of cutaneous nociception in horses\u2014comparison of different locations and environmental conditions","volume":"9","author":"Poller","year":"2013","journal-title":"BMC Vet Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1007\/s11095-007-9470-6","article-title":"Buprederm, a new transdermal delivery system of buprenorphine: pharmacokinetic, efficacy and skin irritancy studies","volume":"25","author":"Park","year":"2008","journal-title":"Pharm Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.2165\/00003495-200363190-00003","article-title":"Transdermal buprenorphine","volume":"63","author":"Evans","year":"2003","journal-title":"Drugs"},{"key":"B30","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/s0149-2918(03)90019-1","article-title":"Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"25","author":"Sittl","year":"2003","journal-title":"Clin Ther"},{"key":"B31","doi-asserted-by":"publisher","first-page":"318","DOI":"10.2460\/javma.238.3.318","article-title":"Efficacy of oral transmucosal and intravenous administration of buprenorphine before surgery for postoperative analgesia in dogs undergoing ovariohysterectomy","volume":"238","author":"Ko","year":"2011","journal-title":"J Am Vet Med Assoc"},{"key":"B32","first-page":"494","article-title":"Clinical efficacy of sustained-release buprenorphine with meloxicam for postoperative analgesia in beagle dogs undergoing ovariohysterectomy","volume":"53","author":"Nunamaker","year":"2014","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.2460\/ajvr.67.10.1675","article-title":"Cardiopulmonary effects of buprenorphine in horses","volume":"67","author":"Carregaro","year":"2006","journal-title":"Am J Vet Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3390\/vetsci9040174","article-title":"Influence of butorphanol, buprenorphine and levomethadone on sedation quality and postoperative analgesia in horses undergoing cheek tooth extraction","volume":"9","author":"Emanuel","year":"2022","journal-title":"Vet Sci"},{"key":"B35","first-page":"35","article-title":"Sedative and cardiopulmonary effects of buprenorphine and xylazine in horses","volume":"75","author":"Cruz","year":"2011","journal-title":"Can J Vet Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/vaa.12316","article-title":"Preliminary investigation comparing a detomidine continuous rate infusion combined with either morphine or buprenorphine for standing sedation in horses","volume":"43","author":"Potter","year":"2016","journal-title":"Vet Anaesth Analg"},{"key":"B37","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/vaa.12055","article-title":"Evaluation of sedation for standing clinical procedures in horses using detomidine combined with buprenorphine","volume":"41","author":"Taylor","year":"2014","journal-title":"Vet Anaesth Analg"},{"key":"B38","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1365-2885.2011.01284.x","article-title":"Pharmacokinetics of intravenous and intramuscular buprenorphine in the horse","volume":"35","author":"Davis","year":"2012","journal-title":"J Vet Pharmacol Ther"},{"key":"B39","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1136\/vr.c7288","article-title":"Assessment of the sedative effects of buprenorphine administered with 10\u2005\u03bcg\/kg detomidine in horses","volume":"168","author":"Love","year":"2011","journal-title":"Vet Rec"},{"key":"B40","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/jvp.12715","article-title":"Pharmacokinetics and physiologic\/behavioral effects of buprenorphine administered sublingually and intravenously to neonatal foals","volume":"42","author":"Grubb","year":"2019","journal-title":"J Vet Pharmacol Ther"},{"key":"B41","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1136\/vr.102729","article-title":"Buprenorphine provides better anaesthetic conditions than butorphanol for field castration in ponies: results of a randomised clinical trial","volume":"175","author":"Rigotti","year":"2014","journal-title":"Vet Rec"},{"key":"B42","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/j.1467-2995.2011.00613.x","article-title":"Intravenous and sublingual buprenorphine in horses: pharmacokinetics and influence of sampling site","volume":"38","author":"Messenger","year":"2011","journal-title":"Vet Anaesth Analg"},{"key":"B43","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1136\/vr.160.23.808","article-title":"Sublingual administration of buprenorphine for long-term analgesia in the horse","volume":"160","author":"Walker","year":"2007","journal-title":"Vet Rec"},{"key":"B44","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.vaa.2018.08.004","article-title":"Colon constipation in horses after sustained-release buprenorphine administration","volume":"45","author":"Levionnois","year":"2018","journal-title":"Vet Anaesth Analg"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1097\/ALN.0b013e318238fea0","article-title":"Buprenorphine metabolites, buprenorphine-3-glucuronide and norbuprenorphine-3-glucuronide, are biologically active","volume":"115","author":"Brown","year":"2011","journal-title":"Anesthesiology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e10069","DOI":"10.1002\/mds3.10069","article-title":"Transdermal drug delivery and patches\u2014an overview","volume":"3","author":"Bird","year":"2020","journal-title":"Med Devices Sens"},{"key":"B47","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2478\/acph-2019-0016","article-title":"Transdermal patches: design and current approaches to painless drug delivery","volume":"69","author":"Al Hanbali","year":"2019","journal-title":"Acta Pharm"},{"key":"B48","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.rvsc.2006.07.015","article-title":"Regional differences in transdermal penetration of fentanyl through equine skin","volume":"82","author":"Mills","year":"2007","journal-title":"Res Vet Sci"},{"key":"B49","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/evj.13424","article-title":"The pharmacokinetics of a fentanyl matrix patch applied at three different anatomical locations in horses","volume":"54","author":"Skrzypczak","year":"2022","journal-title":"Equine Vet J"}],"container-title":["Frontiers in Pain Research"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2024.1373555\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T04:36:20Z","timestamp":1710131780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2024.1373555\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,11]]},"references-count":49,"alternative-id":["10.3389\/fpain.2024.1373555"],"URL":"https:\/\/doi.org\/10.3389\/fpain.2024.1373555","relation":{},"ISSN":["2673-561X"],"issn-type":[{"value":"2673-561X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,11]]},"article-number":"1373555"}}